BioSpace News Archive

Business

Hatchtech Board and Management Changes; Hatchtech Today Announced that Paul MacLeman Has Resigned as CEO

April 21, 2009
·
3 min read
FDA

Biomerica Receives CE Mark Approval for 5-Minute Home Test for Kidney Disease Screening for Diabetic and Hypertensive Individuals

April 21, 2009
·
3 min read
Biotech Beach

Applied Biosystems Scientists Use Next-Generation Sequencing to Associate Methylation Patterns with the Development of Cancer

April 21, 2009
·
1 min read
Drug Development

Elusys Therapeutics, Inc.’ Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study

April 21, 2009
·
3 min read
Drug Development

Dendreon Corporation Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer

April 21, 2009
·
4 min read
Business

Halo Pharmaceutical, Inc. Welcomes Dr. George Bobotas as Its Chief Scientific Officer

April 21, 2009
·
3 min read
Drug Development

Ardea Biosciences, Inc. Announces Positive Results from a Phase 1 Study of Lead Hyperuricemia and Gout Candidate, RDEA594 and a Phase 2a Study of RDEA594’s Prodrug, RDEA806

April 21, 2009
·
1 min read
Deals

Haemonetics Corporation Expands Its Blood Management Leadership With Acquisition of Neoteric Technology Ltd.

April 21, 2009
·
3 min read
Business

HUYA Bioscience International Announces Strategic Alliance With Abbott Laboratories on Drug and Biomarker Development Candidates From China

April 21, 2009
·
3 min read
Business

Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs

April 21, 2009
·
4 min read